SOURCE: Daxor Corp.

Daxor Corp.

October 21, 2014 09:30 ET

Daxor Corporation Announces Research Agreement With Virginia Commonwealth University on Burn Patients

NEW YORK, NY--(Marketwired - Oct 21, 2014) - Dr. Joseph Feldschuh, President and CEO of the Daxor Corporation (NYSE MKT: DXR), announced an agreement with Virginia Commonwealth University (VCU) to do a 40 patient study on burn patients entitled "Measurement of Blood Volume Loss During Burn Surgery." The patients are treated and followed in a special intensive care unit for burn patients.

Dr. Mark Nelson, Principle Investigator for the Burn Study at VCU, stated, "This technology gives us a window into the volume status of critically injured burn patients unlike anything before it. This population has enormous fluid shifts and oozing which results from thermal injury to the skin, which is normally impermeable to water loss. Maintaining ideal blood volume status in these patients is of paramount importance. We believe that the use of this data will significantly increase the survival of critically injured burn patients." This study, headed by Dr. Mark Nelson, will be the first burn unit in the U.S. to conduct routine blood volume measurements on these critically ill patients. 

Dr. Joseph Feldschuh, President of Daxor, stated that at the present time, physicians treating severely burned patients face diagnostic problems in evaluating severe circulatory derangements. These patients are prone to experience sudden drops in blood pressure which may predispose them to kidney failure. The ability to properly evaluate a patient's blood volume status in under an hour will give the treating physicians an opportunity to take preventive measures prior to complications. These complications are similar to the type of circulatory collapse observed in septic patients who have bacterial or viral sepsis, which have high death rates. A previous published study on 100 septic patients in the intensive care unit at the University of Hawaii, The Queen's Medical Center, demonstrated an 8% survival rate for half the patients treated utilizing blood volume measurement vs. a 24% death rate for half the patients treated without blood volume measurements. Dr. Mihae Yu was the senior author.

Virginia Commonwealth University (VCU) is a public research university located in Richmond, Virginia. VCU was founded in 1838 as the medical department of Hampden-Sydney College, becoming the Medical College of Virginia in 1854. With a record $256 million in sponsored research funding in the fiscal year 2011, VCU is designated as a research university with very high research activity by the Carnegie Classification of Institutions of Higher Education.

Contact Information

  • Contact Information:
    Daxor Corporation:
    Diane Meegan
    212-330-8512
    (Investor Relations)
    dmeegan@daxor.com

    Richard Dunn
    212-330-8502
    (Director of Operations)
    rdunn@daxor.com